![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 11, 2018 12:39:15 PM
Do IPIX drugs really matter? Maybe to you from making money perspective but not patients perspective. They are years away from coming to market if at all but world has moved on and got better alternatives.
This seems like a cynical, silly perspective.
Of course drugs that improve patient health and well-being matter. These are some terrible diseases we are dealing with, especially head and neck cancer with oral mucositis. If you had a loved one experience this dreadful condition (like I did), there is no way you would be so crass and cold-hearted with such a statement.
There are NO good options right now to prevent oral mucositis.
Most cancers are horrible death sentences. We will ALWAYS need options to treat cancer, such as a pill to reactivate p53 to help the cancer cells self-destruct.
There is always a need for a safe pill to treat psoriasis - just look at the purported response posted here from one of the subjects in one of the trials and how happy she was.
There is ALWAYS a need for antibiotics with a new mechanism of action such as brilacidin, especially one that is safe and has perfect compliance (a one time infusion).
There is a strong need for people with inflammatory GI conditions, and brilacidin could really help many of them.
To minimize the potential of IPIX's drugs and to say they don't matter to suffering patients is cynical to the extreme, IMO. Just try to put yourself in the patient's position.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM